Loading organizations...
AI-driven drug discovery and precision medicine development.
Exscientia has raised $432.8M across 6 funding rounds.
Key people at Exscientia.
Exscientia was founded by Andrew Hopkins (Co-Founder and CEO).
Exscientia has raised $432.8M in total across 6 funding rounds.
Exscientia was founded by Andrew Hopkins (Co-Founder and CEO).
Exscientia has raised $432.8M in total across 6 funding rounds.
Exscientia's investors include SoftBank Vision Fund 2, BlackRock, Bristol Myers Squibb, Casdin Capital, Andrew Hopkins, Farallon Capital Management, GT Healthcare Capital Partners, Hongkou, Laurion Capital Management, Marshall Wace, Novo Holdings, Pivotal bioVenture Partners.
Key people at Exscientia.
Exscientia has raised $432.8M across 6 funding rounds. Most recently, it raised $225.0M Series D in April 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 27, 2021 | Exscientia | $225.0M Series D | SoftBank Vision Fund 2 | BlackRock, Bristol Myers Squibb, Casdin Capital, Andrew Hopkins, Farallon Capital Management, GT Healthcare Capital Partners, Hongkou, Laurion Capital Management, Marshall Wace, Novo Holdings, Pivotal bioVenture Partners |
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 27, 2021 | $225.0M Series D | SoftBank Vision Fund 2 | BlackRock, Bristol Myers Squibb, Casdin Capital, Andrew Hopkins, Farallon Capital Management, GT Healthcare Capital Partners, Hongkou, Laurion Capital Management, Marshall Wace, Novo Holdings, Pivotal bioVenture Partners |
| Mar 4, 2021 | $100.0M Series C | William Abecassis, Bristol Myers Squibb, Evotec, GT Healthcare Capital Partners, Novo Holdings | |
| Jan 15, 2021 | $4.2M Grant | Bill & Melinda Gates Foundation | |
| May 26, 2020 | $60.0M Series C | Robert Ghenchev | Bristol Myers Squibb, Evotec, GT Healthcare Capital Partners |
| Jan 7, 2019 | $26.0M Series B | Celgene, Evotec, GT Healthcare Capital Partners | |
| Sep 28, 2017 | $17.6M Other Equity | Werner Lanthaler |